Instrumento Inactivo

Otros idiomas Urologix, Inc. Other OTC

Acciones

ULGX

US9172731047

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

A unknown buyer acquired substantially all of the operating assets of Urologix, Inc.	02/02/16
Urologix Conducting A Strategic Review	09/07/15
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015	12/05/15
Urologix, Inc. Appoints Scott M. Madson as Chief Financial Officer Effective April 1, 2015	23/03/15
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2014	05/02/15
Urologix, Inc. Announces Revenue Guidance for Second Quarter Ended on December 31, 2014	12/01/15
Urologix, Inc. Reports Unaudited Earnings Results for the First Quarter Ended September 30, 2014; Provides Cash Flow Guidance for the Fiscal 2015	04/11/14
Urologix, Inc. Announces Executive Changes	19/08/14
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2014; Reports Impairment of Goodwill for the Second Quarter Ended June 30, 2014; Provides Earnings Guidance for the Full Year 2015	19/08/14
Urologix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	28/05/14
Urologix, Inc. Reports Unaudited Earnings Results for the Third Quarter and Nine Months Ended March 31, 2014	06/05/14
Urologix, Inc. Announces Preliminary Unaudited Revenue Results for the Third Quarter Ended March 31, 2014	10/04/14
Urologix Secures Extension of Credit Facility	04/02/14
Urologix, Inc. Reports Unaudited Earnings Results for the Second Quarter and Six Months Ended December 31, 2013	04/02/14
Urologix, Inc. Reports Revenue Results for the Second Quarter Ended December 31, 2013; Withdraws Previously Issued Fiscal Year 2014 Revenue Guidance	08/01/14
Urologix, Inc. Announces Unaudited Earnings Results for the First Quarter Ended September 30, 2013; Reaffirms Revenue Guidance for Fiscal 2014	29/10/13
Urologix, Inc. Reports Unaudited Earnings Results for the Fourth Quarter and Year Ended June 30, 2013; Provides Revenue Guidance for the Fiscal Year 2014; Reports Impairment Charges for the Fourth Quarter Ended June 30, 2013	20/08/13
Urologix, Inc. completed the acquisition of certain assets and Licenses related to Prostiva business from Medtronic VidaMed, Inc.	20/08/13
Urologix, Inc. Reports Revenue Results for the Fourth Quarter and Full Year of Fiscal 2013	01/07/13
Urologix, Inc. Primary Exchange Listing will Change to OTCQB Marketplace from Nasdaq Capital Market	07/06/13

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Urologix, Inc. Other OTC

Acciones

ULGX

US9172731047

Otros idiomas

Filtros